Health Risk of four types of heartburn medication UK doctors has been asked to stop prescribing four types of heartburn medication called Zantac or ranitidine as a “precautionary measure”.

It follows concern in numerous countries that products might contain an impurity that has been linked to cancer.

The four that are recalled are Zantac 150mg/10ml Syrup, Zantac 50mg/2ml Injection, Zantac 150mg Tablets, and Zantac 300mg Tablets.

But patients must keep taking their prescribed medicine, officials advise.

The Medicines and Healthcare Products Regulatory Agency (MHRA) stated that the health risk of discontinuing the medicine is more than the potential risk presented by the contaminant N-nitrosodimethylamine (NDMA).

Anyone who is worried about taking their medication should speak to their doctor or pharmacist.

What is the recall about?

NDMA has been classified as a likely human carcinogen (a substance that can cause cancer) on the basis of animal studies. It is present in some foods and in water supplies but does not pose danger or cause harm when ingested in very low levels.

The MHRA has requested manufacturers to quarantine all commodities which may contain the active pharmaceutical ingredient (API) that is potentially affected by this issue.

The four in the recall are made by GlaxoSmithKline (GSK).

Over-the-counter products (Zantac 75 Relief (PL 02855/0081 [GSL]) and Zantac 75 Tablets (PL 02855/0082 [P]), that are available for people to buy in pharmacies without the need of a prescription, are produced by a different company and are not affected by the recall.

The MHRA is investigating other ranitidine medicines which might also be affected and will provide updates soon.

Shreyas Tanna

About Shreyas Tanna

The winner of Mr. Pune 2009 Pageant, Mr. Shreyas Tanna is currently the young, dashing, and dynamic CEO of a market research company called Research N Reports in Pune. Fondly known as RNR, the company specializes in market research as well as industry analysis, and is closely associated with its parent company Absolute Markets Insights (AMI). Mr. Shreyas Tanna began his corporate journey as the Head of Corporate sales & PR at RED Entertainment while pursuing his degree for MMS (Marketing) from the MGM College of Management, Mumbai. After accomplishing the tedious task of balancing his work and education, he further polished his skills in Corporate Sales, Public Relations, Channel Development, Global Client Engagement, Strategic Consulting, and Brand Development by working with HDFC Life and ResearchMoz Global Pvt. Ltd. His dedication towards his work has even won him accolades such as the National Level Performer 2013 – HDFC Life and Mr. ResearchMoz 2015. A disciplined individual with a loving heart, he is often seen taking crisp walks with an engrossed look and a gentle smile within the premises of his company to interact with the various departments. And he will be usually followed by an adorable trail of his beloved trio of Shih Tzu babies proudly known as Gucci, Drake, and Paris. The most enticing thing that you will notice about this content and proud pet parent is his infectious positivity and the firm belief in his eyes, a reflection of his favorite quote, “LIFE IS BEAUTIFUL!”

View all posts by Shreyas Tanna →